Tipredane
Tipredane (developmental code name SQ-27239) is a synthetic glucocorticoid corticosteroid which was never marketed.[1][2]
Clinical data | |
---|---|
Other names | SQ-27239; 17α-(Ethylthio)-9α-fluoro-11β-hydroxy-20-thiapregn-1,4-diene-3-one; 17α-(Ethylthio)-9α-fluoro-11β-hydroxy-17-(methylthio)androsta-1,4-dien-3-one |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H31FO2S2 |
Molar mass | 410.61 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
References
- Rainsford KD, Velo GP (6 December 2012). New Developments in Antirheumatic Therapy. Springer Science & Business Media. pp. 154, 164. ISBN 978-94-009-1253-3.
- Korting HC, Schafer-Korting M (24 July 1998). The Benefit/Risk Ratio: A Handbook for the Rational Use of Potentially Hazardous Drugs. CRC Press. pp. 363–. ISBN 978-1-4398-0591-6.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.